Fig. 5.

Radar plot for pointed estimates of the likelihood of being helped or harmed for palbociclib, ribociclib, and abemaciclib for progression-free survival [A] and overall survival [B]. Values are displayed on logarithmic scale. Results from the random-effects model were used to compute the LHHs. Higher values correlate to a greater likelihood to benefit than to harm and are plotted closer to the external ring. G = grade.